Abstract
Background/Aims: Hepatocellular carcinoma (HCC) is one of the most common causes of cancer deaths worldwide. Thus, novel therapies are urgently needed. A promising approach is the use of peripheral benzodiazepine receptor (PBR) ligands which have been shown to inhibit the proliferation of various tumors. There exist no functional studies of PBR in HCC
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have